about
LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to ad...
Read More
6.33
-0.46
(-6.77%)
45,557.6
XNAS Volume
XNAS 21 Sep, 2026 4:02 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
LeonaBio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..